Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Lo Re

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Annals of Internal Medicine|April 12, 2014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort studyVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Current HIV Research|July 19, 2014
HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ functionKaku A So-Armah, Joyce Chang, Charles Alcorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
AIDS Research and Treatment|March 20, 2015
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designMari M Kitahata, Daniel R Drozd, Heidi M Crane, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studiesVincent Lo Re, Kevin Haynes, Eileen E Ming, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
BMJ Medicine|June 12, 2023
Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort studyVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected PatientsVincent Lo Re, Craig W Newcomb, Dena M Carbonari, et al.
JAMA|August 16, 2022
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Annals of Internal Medicine|April 12, 2014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort studyVincent Lo Re, Michael J Kallan, Janet P Tate, et al.
Open Forum Infectious Diseases|May 5, 2017
Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis StatusCharitha Gowda, Craig W Newcomb, Qing Liu, et al.
Current HIV Research|July 19, 2014
HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ functionKaku A So-Armah, Joyce Chang, Charles Alcorn, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2017
HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-DimerBarbara S Taylor, Kaku So-Armah, Janet P Tate, et al.
AIDS Research and Treatment|March 20, 2015
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designMari M Kitahata, Daniel R Drozd, Heidi M Crane, et al.
Pharmacoepidemiology and Drug Safety|July 6, 2012
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studiesVincent Lo Re, Kevin Haynes, Eileen E Ming, et al.
Progress in Cardiovascular Diseases|February 19, 2020
FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis CKaku A So-Armah, Joseph K Lim, Vincent Lo Re, et al.
BMJ Medicine|June 12, 2023
Risk of admission to hospital with arterial or venous thromboembolism among patients diagnosed in the ambulatory setting with covid-19 compared with influenza: retrospective cohort studyVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected PatientsVincent Lo Re, Craig W Newcomb, Dena M Carbonari, et al.
JAMA|August 16, 2022
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized PatientsVincent Lo Re, Sarah K Dutcher, John G Connolly, et al.
Pageof 20